0 followers
Cedilla is developing novel small-molecule therapeutics directed to unrecognized allosteric binding sites, providing new ways to target key cancer drivers and treat life threatening diseases.
Industries
Headquarters
Stage
Employees
Links
View full screen
Alexandra Glucksmann
View all
4 members
9 members
2 members
Kymera Therapeutics
2 followers
Cartesian Therapeutics
1 follower
Tempus Labs
12 followers
Ultragenyx Pharmaceutical
5 followers
Biogen
91 followers
Explore more companies
